Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Kidney Protection in TKR Under Sevoflurane
NCT06835010Completed
- Sponsor
- Tanta University
- Start
- May 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Tanta University. Primary endpoint: Percentage Difference in Serum Creatinine levels After Dexmedetomidine Administration at 5 months. Started May 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06835010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835010.